Eksempler på bruk av Should not be used in children and adolescents på Engelsk og deres oversettelse til Norsk
{-}
-
Colloquial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Yellox should not be used in children and adolescents.
Cu-labelled medicinal products should not be used in children and adolescents up to 18 years.
YERVOY should not be used in children and adolescents.
Medicines radiolabelled with Cuprymina should not be used in children and adolescents up to 18 years.
YERVOY should not be used in children and adolescents below 18 years of age until more information becomes available.
Mycophenolate mofetil Teva should not be used in children and adolescents(aged 2 to 18) for heart or.
Caelyx should not be used in children and adolescents, because it is not known how the medicine will affect them.
Zalviso should not be used in children and adolescents below 18 years.
Ibandronic acid Sandoz should not be used in children and adolescents below the age of 18 years.
FORSTEO should not be used in children and adolescents less than 18 years.
Mycophenolate mofetil Teva should not be used in children and adolescents(aged 2 to 18) for heart or liver transplantation.
Efient should not be used in children and adolescents below 18 years of age.
Therefore, Pelzont should not be used in children and adolescents under 18 years of age.
AUBAGIO should not be used in children and adolescents under 18 years of age.
BindRen should not be used in children and adolescents.
Zavicefta should not be used in children and adolescents.
Removab should not be used in children and adolescents under 18 years of age.
KEYTRUDA should not be used in children and adolescents below 18 years of age.
NUEDEXTA should not be used in children and adolescents below the age of 18 years.
Myfenax should not be used in children and adolescents(aged 2 to 18) for heart or liver.
This medicine should not be used in children and adolescents under the age of 18 years as it has not. .
Constella should not be used in children and adolescents as it has not been studied in this population.
This medicine should not be used in children and adolescents as it has not been studied enough in these populations.
This medicine should not be used in children and adolescents(< 18 years) because the safety and efficacy have not yet been fully established.
Duloxetine should not be used in children and adolescents under the age of 18 years for the treatment of major depressive disorder because of safetyand efficacy concerns(see sections 4.4, 4.8 and 5.1).